本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

70.12
-0.1000-0.14%
盤後70.120.00000.00%16:10 EDT
成交量:37.08萬
成交額:2,601.99萬
市值:29.77億
市盈率:-44.10
高:71.37
開:69.06
低:69.01
收:70.22
52周最高:85.25
52周最低:38.51
股本:4,244.91萬
流通股本:3,035.16萬
量比:0.72
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-1.5900
每股收益(LYR):-1.5900
淨資產收益率:-23.39%
總資產收益率:-9.45%
市淨率:8.67
市盈率(LYR):-44.10

資料載入中...

2025/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

重要事件披露

Form 8-K - Current report
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/17

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]